PMFA
DFTX

Plante Moran Financial Advisors’s Definium Therapeutics DFTX Stock Holding History

Plante Moran Financial Advisors’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$680 Hold
36
– – ﹤0.01% 679
2025
Q4 		$482 Hold
36
– – ﹤0.01% 763
2025
Q3 		$424 Hold
36
– – ﹤0.01% 739
2025
Q2 		$234 Hold
36
– – ﹤0.01% 748
2025
Q1 		$211 Hold
36
– – ﹤0.01% 773
2024
Q4 		$251 Hold
36
– – ﹤0.01% 883
2024
Q3 		$205 Hold
36
– – ﹤0.01% 852
2024
Q2 		$260 Hold
36
– – ﹤0.01% 755
2024
Q1 		$338 Hold
36
– – ﹤0.01% 811
2023
Q4 		$132 Hold
36
– – ﹤0.01% 796
2023
Q3 		$113 Hold
36
– – ﹤0.01% 742
2023
Q2 		$129 Hold
36
– – ﹤0.01% 766
2023
Q1 		$114 Hold
36
– – ﹤0.01% 769
2022
Q4 		$79 Hold
36
– – ﹤0.01% 834
2022
Q3 		$0 Hold
36
– – ﹤0.01% 993
2022
Q2 		$0 Buy
+36
New +$455 ﹤0.01% 1023

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Plante Moran Financial Advisors's DFTX Position: Q1 2026 in Review

Plante Moran Financial Advisors held its Definium Therapeutics (DFTX) position steady in Q1 2026 at 36 shares worth $680. The position accounts for ﹤0.01% of the portfolio, ranked #679.

Plante Moran Financial Advisors first reported a position in DFTX in Q2 2022 and has held it in 16 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Plante Moran Financial Advisors held 36 shares of Definium Therapeutics worth $680 as of Q1 2026.
  • Plante Moran Financial Advisors left its Definium Therapeutics share count unchanged in Q1 2026.
  • Definium Therapeutics made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q1 2026, its #679 holding.
  • Plante Moran Financial Advisors first reported a position in Definium Therapeutics in Q2 2022 and has held it in 16 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q1 2026, filed 5 May 2026.